112 related articles for article (PubMed ID: 23184331)
1. Prognostic impact of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in malignant gliomas.
Wang XW; Boisselier B; Rossetto M; Marie Y; Idbaih A; Mokhtari K; Gousias K; Hoang-Xuan K; Delattre JY; Simon M; Labussière M; Sanson M
Cancer; 2013 Feb; 119(4):806-13. PubMed ID: 23184331
[TBL] [Abstract][Full Text] [Related]
2. A population-based study of high-grade gliomas and mutated isocitrate dehydrogenase 1.
Dahlrot RH; Kristensen BW; Hjelmborg J; Herrstedt J; Hansen S
Int J Clin Exp Pathol; 2013; 6(1):31-40. PubMed ID: 23236540
[TBL] [Abstract][Full Text] [Related]
3. Molecular subtypes of glioblastoma are relevant to lower grade glioma.
Guan X; Vengoechea J; Zheng S; Sloan AE; Chen Y; Brat DJ; O'Neill BP; de Groot J; Yust-Katz S; Yung WK; Cohen ML; Aldape KD; Rosenfeld S; Verhaak RG; Barnholtz-Sloan JS
PLoS One; 2014; 9(3):e91216. PubMed ID: 24614622
[TBL] [Abstract][Full Text] [Related]
4. Imaging growth and isocitrate dehydrogenase 1 mutation are independent predictors for diffuse low-grade gliomas.
Gozé C; Blonski M; Le Maistre G; Bauchet L; Dezamis E; Page P; Varlet P; Capelle L; Devaux B; Taillandier L; Duffau H; Pallud J
Neuro Oncol; 2014 Aug; 16(8):1100-9. PubMed ID: 24847087
[TBL] [Abstract][Full Text] [Related]
5. Mutant IDH1 and thrombosis in gliomas.
Unruh D; Schwarze SR; Khoury L; Thomas C; Wu M; Chen L; Chen R; Liu Y; Schwartz MA; Amidei C; Kumthekar P; Benjamin CG; Song K; Dawson C; Rispoli JM; Fatterpekar G; Golfinos JG; Kondziolka D; Karajannis M; Pacione D; Zagzag D; McIntyre T; Snuderl M; Horbinski C
Acta Neuropathol; 2016 Dec; 132(6):917-930. PubMed ID: 27664011
[TBL] [Abstract][Full Text] [Related]
6. Adult brainstem gliomas: Correlation of clinical and molecular features.
Theeler BJ; Ellezam B; Melguizo-Gavilanes I; de Groot JF; Mahajan A; Aldape KD; Bruner JM; Puduvalli VK
J Neurol Sci; 2015; 353(1-2):92-7. PubMed ID: 25934342
[TBL] [Abstract][Full Text] [Related]
7. Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis.
Zeng C; Song X; Zhang Z; Cai Q; Cai J; Horbinski C; Hu B; Cheng SY; Zhang W
Acta Neuropathol Commun; 2023 Aug; 11(1):133. PubMed ID: 37580817
[TBL] [Abstract][Full Text] [Related]
8. Integrative analysis of the cuproptosis-related gene ATP7B in the prognosis and immune infiltration of IDH1 wild-type glioma.
Zhang K; Qu C; Zhou P; Yang Z; Wu X
Gene; 2024 May; 905():148220. PubMed ID: 38286269
[TBL] [Abstract][Full Text] [Related]
9. Integrated genomic characterization of IDH1-mutant glioma malignant progression.
Bai H; Harmancı AS; Erson-Omay EZ; Li J; Coşkun S; Simon M; Krischek B; Özduman K; Omay SB; Sorensen EA; Turcan Ş; Bakırcığlu M; Carrión-Grant G; Murray PB; Clark VE; Ercan-Sencicek AG; Knight J; Sencar L; Altınok S; Kaulen LD; Gülez B; Timmer M; Schramm J; Mishra-Gorur K; Henegariu O; Moliterno J; Louvi A; Chan TA; Tannheimer SL; Pamir MN; Vortmeyer AO; Bilguvar K; Yasuno K; Günel M
Nat Genet; 2016 Jan; 48(1):59-66. PubMed ID: 26618343
[TBL] [Abstract][Full Text] [Related]
10. IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients.
Crucitta S; Pasqualetti F; Gonnelli A; Ruglioni M; Luculli GI; Cantarella M; Ortenzi V; Scatena C; Paiar F; Naccarato AG; Danesi R; Del Re M
BMC Cancer; 2024 Jan; 24(1):31. PubMed ID: 38172718
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic
Beyer SJ; Bell EH; McElroy JP; Fleming JL; Cui T; Becker A; Bassett E; Johnson B; Gulati P; Popp I; Staszewski O; Prinz M; Grosu AL; Haque SJ; Chakravarti A
Oncotarget; 2018 Dec; 9(98):37097-37111. PubMed ID: 30647847
[TBL] [Abstract][Full Text] [Related]
12. A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation.
Jenkins RB; Xiao Y; Sicotte H; Decker PA; Kollmeyer TM; Hansen HM; Kosel ML; Zheng S; Walsh KM; Rice T; Bracci P; McCoy LS; Smirnov I; Patoka JS; Hsuang G; Wiemels JL; Tihan T; Pico AR; Prados MD; Chang SM; Berger MS; Caron AA; Fink SR; Halder C; Rynearson AL; Fridley BL; Buckner JC; O'Neill BP; Giannini C; Lachance DH; Wiencke JK; Eckel-Passow JE; Wrensch MR
Nat Genet; 2012 Oct; 44(10):1122-5. PubMed ID: 22922872
[TBL] [Abstract][Full Text] [Related]
13. An integrated genomic analysis of human glioblastoma multiforme.
Parsons DW; Jones S; Zhang X; Lin JC; Leary RJ; Angenendt P; Mankoo P; Carter H; Siu IM; Gallia GL; Olivi A; McLendon R; Rasheed BA; Keir S; Nikolskaya T; Nikolsky Y; Busam DA; Tekleab H; Diaz LA; Hartigan J; Smith DR; Strausberg RL; Marie SK; Shinjo SM; Yan H; Riggins GJ; Bigner DD; Karchin R; Papadopoulos N; Parmigiani G; Vogelstein B; Velculescu VE; Kinzler KW
Science; 2008 Sep; 321(5897):1807-12. PubMed ID: 18772396
[TBL] [Abstract][Full Text] [Related]
14. A noncoding single-nucleotide polymorphism at 8q24 drives
Yanchus C; Drucker KL; Kollmeyer TM; Tsai R; Winick-Ng W; Liang M; Malik A; Pawling J; De Lorenzo SB; Ali A; Decker PA; Kosel ML; Panda A; Al-Zahrani KN; Jiang L; Browning JWL; Lowden C; Geuenich M; Hernandez JJ; Gosio JT; Ahmed M; Loganathan SK; Berman J; Trcka D; Michealraj KA; Fortin J; Carson B; Hollingsworth EW; Jacinto S; Mazrooei P; Zhou L; Elia A; Lupien M; He HH; Murphy DJ; Wang L; Abyzov A; Dennis JW; Maass PG; Campbell K; Wilson MD; Lachance DH; Wrensch M; Wiencke J; Mak T; Pennacchio LA; Dickel DE; Visel A; Wrana J; Taylor MD; Zadeh G; Dirks P; Eckel-Passow JE; Attisano L; Pombo A; Ida CM; Kvon EZ; Jenkins RB; Schramek D
Science; 2022 Oct; 378(6615):68-78. PubMed ID: 36201590
[TBL] [Abstract][Full Text] [Related]
15. TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas.
Li J; Wang X; Chen L; Zhang J; Zhang Y; Ren X; Sun J; Fan X; Fan J; Li T; Tong L; Yi L; Chen L; Liu J; Shang G; Ren X; Zhang H; Yu S; Ming H; Huang Q; Dong J; Zhang C; Yang X
Cancer Gene Ther; 2022 Aug; 29(8-9):1117-1129. PubMed ID: 34992215
[TBL] [Abstract][Full Text] [Related]
16. Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.
Ostrom QT; Kinnersley B; Armstrong G; Rice T; Chen Y; Wiencke JK; McCoy LS; Hansen HM; Amos CI; Bernstein JL; Claus EB; Eckel-Passow JE; Il'yasova D; Johansen C; Lachance DH; Lai RK; Merrell RT; Olson SH; Sadetzki S; Schildkraut JM; Shete S; Rubin JB; Andersson U; Rajaraman P; Chanock SJ; Linet MS; Wang Z; Yeager M; ; Houlston RS; Jenkins RB; Wrensch MR; Melin B; Bondy ML; Barnholtz-Sloan JS
Int J Cancer; 2018 Nov; 143(10):2359-2366. PubMed ID: 30152087
[TBL] [Abstract][Full Text] [Related]
17. Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients.
Jacobs DI; Liu Y; Gabrusiewicz K; Tsavachidis S; Armstrong GN; Zhou R; Wei J; Ivan C; Calin G; Molinaro AM; Rice T; Bracci PM; Hansen HM; Wiencke JK; Wrensch MR; Heimberger AB; Bondy ML
J Neurooncol; 2018 Jan; 136(1):33-39. PubMed ID: 28965162
[TBL] [Abstract][Full Text] [Related]
18. Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial.
de la Fuente MI; Colman H; Rosenthal M; Van Tine BA; Levacic D; Walbert T; Gan HK; Vieito M; Milhem MM; Lipford K; Forsyth S; Guichard SM; Mikhailov Y; Sedkov A; Brevard J; Kelly PF; Mohamed H; Monga V
Neuro Oncol; 2023 Jan; 25(1):146-156. PubMed ID: 35639513
[TBL] [Abstract][Full Text] [Related]
19. The genomic alterations in glioblastoma influence the levels of CSF metabolites.
Wang DH; Fujita Y; Dono A; Rodriguez Armendariz AG; Shah M; Putluri N; Pichardo-Rojas PS; Patel CB; Zhu JJ; Huse JT; Parker Kerrigan BC; Lang FF; Esquenazi Y; Ballester LY
Acta Neuropathol Commun; 2024 Jan; 12(1):13. PubMed ID: 38243318
[TBL] [Abstract][Full Text] [Related]
20. Shedding Light on
Hollon TC; Orringer DA
Clin Cancer Res; 2018 Jun; 24(11):2467-2469. PubMed ID: 29440182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
